Xiaofan Zhu
Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC · Hematology Hospital of the Chinese Academy of Medical Sciences · Chinese Academy of Medical Sciences Haematological Diseases Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
15
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers in childhood acute lymphoblastic leukemia
14
PubMed author-name match
Trials
Studies that name Xiaofan Zhu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:13 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07751588 · Plasma ctDNA Monitoring in Pediatric Acute LeukemiaInstitute of Hematology & Blood Diseases Hospital, China · not yet recruiting · Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia · principal investigator
- Ph3NCT07152041 · Newly-diagnosed Pediatric Ph-positive B-ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), Childhood Leukemia, Acute Lymphoblastic · principal investigator
- Ph2/Ph3NCT06882057 · Newly-diagnosed Low Risk Pediatric B-cell ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL) · principal investigator
- Ph2/Ph3NCT06855810 · Newly-diagnosed Pediatric T-cell ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma · principal investigator
- Ph2/Ph3NCT06764238 · Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL) · principal investigator
- Ph2NCT06179524 · CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALLBeijing Yongtai Ruike Biotechnology Company Ltd · recruiting · Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic Leukemia · principal investigator
- Ph1/Ph2NCT06052813 · A Study of BN104 in the Treatment of Acute LeukemiaInstitut de Recherches Internationales Servier (I.R.I.S.) · active not recruiting · ALL, Adult, AML, Adult, Acute Leukaemia · principal investigator
- Ph1NCT05727683 · CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic LeukemiaShanghai Ming Ju Biotechnology Co., Ltd. · unknown · Acute Lymphocytic Leukemia · principal investigator
- Ph1/Ph2NCT05667506 · A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)Juventas Cell Therapy Ltd. · recruiting · B-cell Acute Lymphoblastic Leukemia · principal investigator
- Early Ph1NCT05519384 · Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid LeukemiaInstitute of Hematology & Blood Diseases Hospital, China · unknown · Acute Myeloid Leukemia, Childhood, Relapsed Leukemia, Refractory Leukemia · principal investigator
- Ph1NCT05495035 · Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALLInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed Leukemia · principal investigator
- Ph4NCT02953730 · The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and AdolescentsChinese Academy of Medical Sciences · completed · Acute Lymphoid Leukemia · principal investigator
- Ph4NCT02218437 · Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived）Chinese Academy of Medical Sciences · unknown · Complications of Organ Transplant Stem Cells Umbilical Cord · principal investigator
- Ph4NCT01990807 · Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic LeukemiaChinese Academy of Medical Sciences · unknown · Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Ph^1^, Absent, B-cell Childhood Acute Lymphoblastic Leukemia · principal investigator
- Ph4NCT01191541 · Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)Xiaofan Zhu · completed · Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 13:13 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.JAMA Oncol · 2020202 citationsRCR 9.1
- Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: The first nation-wide prospective multicenter study in China.Am J Hematol · 2018113 citationsRCR 4.3
- 87 citationsRCR 4.9
- Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.J Hematol Oncol · 202081 citationsRCR 2.9
- 80 citationsRCR 4.8
- Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children's Cancer Group.Arch Dis Child · 201962 citationsRCR 2.9
- Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T Cells.Clin Lymphoma Myeloma Leuk · 202024 citationsRCR 0.9
- Venous Thromboembolism After Peripherally Inserted Central Catheters Placement in Children With Acute Leukemia: A Single-center Retrospective Cohort Study.J Pediatr Hematol Oncol · 20208 citationsRCR 0.6
- 5 citationsRCR 0.2
- Individualized Use of 6-Mercaptopurine in Chinese Children with ALL: A Multicenter Randomized Controlled Trial.Clin Pharmacol Ther · 20245 citationsRCR 1.0